Prosecution Insights
Last updated: October 25, 2026

Alford Law Group, Inc.

Technology areas: Biotechnology & Pharmaceuticals • Communications

14 pending office actions • 5 clients • 12 examiners • 10 art units • 0 of 14 (0%) have an AI response strategy ready

Analysis

Alford Law Group, Inc. handles Biotechnology & Pharmaceuticals matters with 14 pending office actions. Its career record contains 283 applications, providing a broader basis for assessing prosecution outcomes than the pending docket alone.

The resolved allowance rate is 86.81%, while the average is 2.7 office actions per allowance. Together, these figures describe a record in which resolved matters frequently reach allowance, with multiple examination exchanges commonly preceding an allowance. For practitioners, the data supports planning for continued amendment or response work rather than assuming that an initial filing will proceed without substantive examination.

The combination of an active biotechnology and pharmaceutical docket with historical prosecution results can inform portfolio review, response staffing, and expectations for examination effort. The figures do not identify individual technologies, claim types, or the timing of particular outcomes.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=283 apps, methodology: how we score firms)

86.8%
Allowance Rate
n=283
+0.44σ
Allowance Rate (norm)
n=283
2.7
OAs to Allowance
n=125
-0.46σ
OAs to Allow (norm)
n=125
1074 days
Time to Allowance
n=125
+2.6pp
Interview Lift
n=283
33.3%
RCE Rate
n=283
1.3%
Appeal Rate
n=283

Rejection Performance (% of received rejections ultimately overcome)

60.0%
§101 Overcome
n=20
76.3%
§102 Overcome
n=59
72.2%
§103 Overcome
n=79
66.2%
§112 Overcome
n=68

Specialization & Scale

G01N, G06F, G06V
Top CPC Subclasses
34%
Top-3 CPC Share
n=283
2
Practitioners
n=283
141.5
Apps / Practitioner
n=283

Portfolio Summary

14
Total Pending OAs
10
Non-Final OAs
4
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
2
Due this month
2
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (2)Due ≤ 60 days (2)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

9
Hard (64%)
3
Medium (21%)
2
Easy (14%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other3 (21%)
§103 only1 (7%)
§112 only2 (14%)
Double-patenting + other2 (14%)
Multi-statute (no §101)6 (43%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

7
Life Sciences
50% of docket
2
Information Tech
14% of docket
3
Communications
21% of docket
2
Semiconductors
14% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

140 h
Manual time on pending OAs
28 h
Time saved (low, 20%)
49 h
Time saved (mid, 35%)
1.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
JACKSON, JAKIEDA R 2 74.1% +15.8%
IVICH, FERNANDO NMN 2 52.4% +72.2%
OGUNTADE, ELIZABETH BISOLA 1 50.0% +100.0%
SHALU, ZELALEM W 1 31.9% +21.7%
TRAN, CHAU NGUYEN BICH 1 31.6% +45.2%
STREGE, JOHN B 1 87.0% +13.9%
RAMADAN, OMAR 1 25.4% +56.5%
KWAK, DEAN P 1 58.8% +37.1%
LIPMAN, JACOB 1 83.3% +12.8%
COOK, JONATHON 1 81.6% +17.1%

Hard Cases (9)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17994395 METHODS, APPARATUS, AND SYSTEMS FOR AN OPTICAL FIBER FORWARD SCATTER CHANNEL IN FLOW CYTOMETERS COOK, JONATHON 77d overdue
18297615 METHODS AND APPARATUS FOR REMOVABLE NOZZLE WITH CAM LATCH ENGAGEMENT IN FLOW CYTOMETERS KWAK, DEAN P 44d overdue
16418942 FAST RECOMPENSATION OF FLOW CYTOMETERY DATA FOR SPILLOVER READJUSTMENTS BRYANT, REBECCA CAROLE 14d
18239137 ADAPTABLE SYSTEMS FOR DISCOVERING INTENT FROM ENTERPRISE DATA SHALU, ZELALEM W 55d
18173051 ELECTRONIC DEVICES WITH A STATIC ARTIFICIAL INTELLIGENCE MODEL FOR CONTEXTUAL SITUATIONS, INCLUDING AGE BLOCKING FOR VAPING AND IGNITION START, USING DATA ANALYSIS AND OPERATING METHODS THEREOF LIPMAN, JACOB 56d
18215158 AUTO HIGH CONTENT SCREENING USING ARTIFICIAL INTELLIGENCE FOR DRUG COMPOUND DEVELOPMENT STREGE, JOHN B 86d
18927838 LARGE LANGUAGE MACHINE LEARNING MODELS FOR SERVICE PROVIDER VIRTUAL COMMUNICATION SYSTEMS JACKSON, JAKIEDA R —
18335091 METHODS AND APARATUS FOR A MOUSE SURFACE AND INTRACELLULAR FLOW CYTOMETRY IMMUNOPHENOTYPING KIT RAMADAN, OMAR —

Interview Candidates (12)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17994395 METHODS, APPARATUS, AND SYSTEMS FOR AN OPTICAL FIBER FORWARD SCATTER CHANNEL IN FLOW CYTOMETERS COOK, JONATHON 77d overdue
18297615 METHODS AND APPARATUS FOR REMOVABLE NOZZLE WITH CAM LATCH ENGAGEMENT IN FLOW CYTOMETERS KWAK, DEAN P 44d overdue
16992489 SYSTEM AND METHOD USING CLOUD STRUCTURES IN REAL TIME SPEECH AND TRANSLATION INVOLVING MULTIPLE LANGUAGES, CONTEXT SETTING, AND TRANSCRIPTING FEATURES JACKSON, JAKIEDA R 12d
18239137 ADAPTABLE SYSTEMS FOR DISCOVERING INTENT FROM ENTERPRISE DATA SHALU, ZELALEM W 55d
18173051 ELECTRONIC DEVICES WITH A STATIC ARTIFICIAL INTELLIGENCE MODEL FOR CONTEXTUAL SITUATIONS, INCLUDING AGE BLOCKING FOR VAPING AND IGNITION START, USING DATA ANALYSIS AND OPERATING METHODS THEREOF LIPMAN, JACOB 56d
18215158 AUTO HIGH CONTENT SCREENING USING ARTIFICIAL INTELLIGENCE FOR DRUG COMPOUND DEVELOPMENT STREGE, JOHN B 86d
18927838 LARGE LANGUAGE MACHINE LEARNING MODELS FOR SERVICE PROVIDER VIRTUAL COMMUNICATION SYSTEMS JACKSON, JAKIEDA R —
18747407 ULTRA-BRIGHT NANOPARTICLE FLUORESCENT DYE COMPLEXES IVICH, FERNANDO NMN —

Client Portfolio (5 clients)

Top Art Units

Art UnitApps
26572
16782
16772
28772
16571
21451
26691
17981
24311
16851

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18927838 LARGE LANGUAGE MACHINE LEARNING MODELS FOR SERVICE PROVIDER VIRTUAL COMMUNICATION SYSTEMS Predii, Inc. JACKSON, JAKIEDA R 2657 §101§102 Non-Final OA — Pending Oct 25, 2024
18747407 ULTRA-BRIGHT NANOPARTICLE FLUORESCENT DYE COMPLEXES Cytek Biosciences, Inc. IVICH, FERNANDO NMN 1657 §102§112DP Non-Final OA — Pending Jun 18, 2024
18539182 ACCURATE ENUMERATION OF LEUKOCYTE SUBSETS IN PERIPHERAL BLOOD WITH A 15-COLOR IMMUNOPROFILING PANEL USING A SPECTRAL FLOW CYTOMETER Cytek Biosciences, Inc. IVICH, FERNANDO NMN 1678 §112 Non-Final OA — Pending Dec 13, 2023
18491741 HIGH PARAMETER 20 COLOR PANEL FOR EFFECTIVE DETECTION OF ABERRANT CELLS IN ACUTE MYELOID LEUKEMIA Cytek Biosciences, Inc. OGUNTADE, ELIZABETH BISOLA 1677 §112 Final Rejection — Pending Oct 20, 2023
18239137 ADAPTABLE SYSTEMS FOR DISCOVERING INTENT FROM ENTERPRISE DATA Predii, Inc. SHALU, ZELALEM W 2145 §101§103 Non-Final OA 55d Pending Aug 29, 2023
18353056 B CELL MONITORING REAGENT PANEL AND REAGENT KIT FOR ANALYZING B CELL SUBSETS IN ANTI-CD20 TREATED AUTOIMMUNE PATIENTS Cytek Biosciences, Inc. TRAN, CHAU NGUYEN BICH 1677 §103§112DP Non-Final OA — Pending Jul 14, 2023
18215158 AUTO HIGH CONTENT SCREENING USING ARTIFICIAL INTELLIGENCE FOR DRUG COMPOUND DEVELOPMENT Viqi, Inc. STREGE, JOHN B 2669 §103§112 Non-Final OA 86d Pending Jun 27, 2023
18335091 METHODS AND APARATUS FOR A MOUSE SURFACE AND INTRACELLULAR FLOW CYTOMETRY IMMUNOPHENOTYPING KIT Cytek Biosciences, Inc. RAMADAN, OMAR 1678 §102§112 Non-Final OA — Pending Jun 14, 2023
18297615 METHODS AND APPARATUS FOR REMOVABLE NOZZLE WITH CAM LATCH ENGAGEMENT IN FLOW CYTOMETERS Cytek Biosciences, Inc. KWAK, DEAN P 1798 §102§103§112 Final Rejection 44d overdue Pending Apr 08, 2023
18173051 ELECTRONIC DEVICES WITH A STATIC ARTIFICIAL INTELLIGENCE MODEL FOR CONTEXTUAL SITUATIONS, INCLUDING AGE BLOCKING FOR VAPING AND IGNITION START, USING DATA ANALYSIS AND OPERATING METHODS THEREOF Aerendir Mobile Inc. LIPMAN, JACOB 2431 §103§112 Final Rejection 56d Pending Mar 04, 2023
17994395 METHODS, APPARATUS, AND SYSTEMS FOR AN OPTICAL FIBER FORWARD SCATTER CHANNEL IN FLOW CYTOMETERS Cytek Biosciences, Inc. COOK, JONATHON 2877 §102§103 Non-Final OA 77d overdue Pending Nov 28, 2022
17650067 MACHINE LEARNING FOR EARLY DETECTION OF CELLULAR MORPHOLOGICAL CHANGES Viqi, Inc. FONSECA LOPEZ, FRANCINI ALVARENGA 1685 §101§103 Final Rejection — Pending Feb 04, 2022
16992489 SYSTEM AND METHOD USING CLOUD STRUCTURES IN REAL TIME SPEECH AND TRANSLATION INVOLVING MULTIPLE LANGUAGES, CONTEXT SETTING, AND TRANSCRIPTING FEATURES Wordly Inc. JACKSON, JAKIEDA R 2657 §103 Non-Final OA 12d Pending Aug 13, 2020
16418942 FAST RECOMPENSATION OF FLOW CYTOMETERY DATA FOR SPILLOVER READJUSTMENTS Cytek Biosciences, Inc. BRYANT, REBECCA CAROLE 2877 §102§103§112 Non-Final OA 14d Pending May 21, 2019

Managing Alford Law Group, Inc.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Alford Law Group, Inc.'s patent allowance rate?

86.8% of resolved applications prosecuted by Alford Law Group, Inc. were allowed, across 283 applications in USPTO records.

How many office actions does Alford Law Group, Inc. average before allowance?

2.70 office actions per allowed application on average.

How many pending office actions does Alford Law Group, Inc. have?

14 pending office actions as of October 2026, for 5 clients, before 12 examiners in 10 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month